WO2001090123A3 - Haplotypes du gene agtrl1 - Google Patents

Haplotypes du gene agtrl1 Download PDF

Info

Publication number
WO2001090123A3
WO2001090123A3 PCT/US2001/016906 US0116906W WO0190123A3 WO 2001090123 A3 WO2001090123 A3 WO 2001090123A3 US 0116906 W US0116906 W US 0116906W WO 0190123 A3 WO0190123 A3 WO 0190123A3
Authority
WO
WIPO (PCT)
Prior art keywords
agtrl1
gene
haplotypes
disclosed
polymorphisms
Prior art date
Application number
PCT/US2001/016906
Other languages
English (en)
Other versions
WO2001090123A2 (fr
Inventor
Stefanie E Kliem
Chad Messer
Debra A Tanguay
Original Assignee
Genaissance Pharmaceuticals
Stefanie E Kliem
Chad Messer
Debra A Tanguay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Stefanie E Kliem, Chad Messer, Debra A Tanguay filed Critical Genaissance Pharmaceuticals
Priority to AU2001264937A priority Critical patent/AU2001264937A1/en
Publication of WO2001090123A2 publication Critical patent/WO2001090123A2/fr
Publication of WO2001090123A3 publication Critical patent/WO2001090123A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne de nouveaux polymorphismes mononucléotidiques dans le gène humain de type récepteur 1 d'angiotensine (AGTRL1). Par ailleurs, cette invention concerne divers génotypes, haplotypes et paires d'haplotypes du gène AGTRL1 existant dans la population en question. Cette invention concerne également des compositions et des méthodes d'haplotypage et/ou génotypage du gène AGTRL1 chez un individu. Enfin, cette invention concerne des polynucléotides contenant un ou plusieurs des polymorphismes AGTRL1 précités.
PCT/US2001/016906 2000-05-23 2001-05-23 Haplotypes du gene agtrl1 WO2001090123A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001264937A AU2001264937A1 (en) 2000-05-23 2001-05-23 Haplotypes of the agtrl1 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20626400P 2000-05-23 2000-05-23
US60/206,264 2000-05-23

Publications (2)

Publication Number Publication Date
WO2001090123A2 WO2001090123A2 (fr) 2001-11-29
WO2001090123A3 true WO2001090123A3 (fr) 2002-07-11

Family

ID=22765634

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/016906 WO2001090123A2 (fr) 2000-05-23 2001-05-23 Haplotypes du gene agtrl1

Country Status (2)

Country Link
AU (1) AU2001264937A1 (fr)
WO (1) WO2001090123A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8673848B2 (en) 2012-01-27 2014-03-18 Novartis Ag Synthetic apelin mimetics for the treatment of heart failure
UY35144A (es) 2012-11-20 2014-06-30 Novartis Ag Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca
US8921307B2 (en) 2012-11-20 2014-12-30 Novartis Ag Synthetic linear apelin mimetics for the treatment of heart failure
AU2014293386B2 (en) 2013-07-25 2016-11-17 Novartis Ag Cyclic polypeptides for the treatment of heart failure
EP3024492A2 (fr) 2013-07-25 2016-06-01 Novartis AG Bioconjugués de polypeptides d'apeline synthétiques

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000014220A1 (fr) * 1998-09-08 2000-03-16 Schering Aktiengesellschaft Procedes et compositions modulant l'interaction entre le recepteur apj et le virus vih

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000014220A1 (fr) * 1998-09-08 2000-03-16 Schering Aktiengesellschaft Procedes et compositions modulant l'interaction entre le recepteur apj et le virus vih

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
O'DOWD ET AL.: "A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11", GENE, vol. 136, no. 1-2, December 1993 (1993-12-01), pages 355 - 360, XP002906432 *

Also Published As

Publication number Publication date
WO2001090123A2 (fr) 2001-11-29
AU2001264937A1 (en) 2001-12-03

Similar Documents

Publication Publication Date Title
WO2001079229A3 (fr) Haplotypes du gene cxcr4
WO2001090123A3 (fr) Haplotypes du gene agtrl1
WO2001079234A3 (fr) Haplotypes du gene apoe
WO2001079230A3 (fr) Haplotypes du gene ugt1a1
WO2001077124A3 (fr) Haplotypes du gene apoa4
WO2001079228A3 (fr) Haplotypes du gene f12
WO2001077363A3 (fr) Haplotypes du gene impdh2
WO2001079240A3 (fr) Haplotypes du gene rangap1
WO2001079218A3 (fr) Haplotypes du gene calm1
WO2001079232A3 (fr) Haplotypes du gene mpl
WO2001077129A3 (fr) Haplotypes du gene apoc1
WO2001077131A3 (fr) Haplotypes du gene bglap
WO2001079974A3 (fr) Haplotypes du gene f9
WO2001079237A3 (fr) Haplotypes du gene galr1
WO2001072965A3 (fr) Haplotypes du gene fkbp8
WO2001079219A3 (fr) Haplotypes du gene ache
WO2001079223A3 (fr) Haplotypes du gene akr1b1
WO2001090127A3 (fr) Haplotypes du gene de hoxd3
WO2001077132A3 (fr) Haplotypes du gene il5
WO2001079238A3 (fr) Haplotypes du gene mmp3
WO2001079221A3 (fr) Haplotypes du gene il8rb
WO2001077125A3 (fr) Haplotypes du gene ccr5
WO2001072966A3 (fr) Haplotypes du gene pltp
WO2002055534A3 (fr) Haplotypes du gene f2rli
WO2001083499A3 (fr) Haplotypes du gene de l'il8

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP